Dr. Joachim Schorr joined Gulagen in 1992 as Project Manager and later had responsibilities as Group and Business Development Manager. In 1999 Dr. Schorr became Vice President Research & Development with the responsibility for the world-wide QIAGEN R&D activities. In 2004 Dr. Schorr became QIAGEN's Managing Director and Senior Vice President Research & Development.   Before joining QIAGEN Dr. Schorr worked for the pharmaceutical company Hoechst on the development of oral malaria vaccines and was awarded with the IHK research award in 1991. Dr. Schorr holds a Ph.D. in Molecular Biology and Virology, which he received at the University of Cologne. Dr. Schorr has been a co-founder and is Board Member of Coley Pharmaceuticals, EnPharma Pharmaceuticals, and QBM Cell Sciences.